MedTrace Logo

New Biopsy Needle - Evaluation of Prostate Biopsy Quality

NCT04091230 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-02-10

No results posted yet for this study

Summary

Patient blinded randomized prospective trial evaluating prostate biopsy quality of a novel biopsy needle.

Conditions

  • Prostate Cancer (Diagnosis)

Interventions

DEVICE

TRUSbx

Trans Rectal UltraSound guided Prostate Biopsy

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Adam Linder, MD, PhD · Lund University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-10
Primary Completion
2019-10-30
Completion
2019-11-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04091230 on ClinicalTrials.gov